Clinical trials
Central Nervous System Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2010 | 1 |
| 2015 | 1 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Active, not recruiting | 9 |
| Recruiting | 4 |
| Unknown status | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 18 |
| National Cancer Institute (NCI) | 7 |
| Eli Lilly and Company | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| St. Jude Children's Research Hospital | 3 |
| Children's Hospital Los Angeles | 2 |
| AbbVie | 1 |
| Australian & New Zealand Children's Haematology/Oncology Group | 1 |
| BeiGene USA, Inc. | 1 |
| Blueprint Medicines Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Central Nervous System Neoplasms | 46 |
| Brain Neoplasms | 19 |
| Astrocytoma | 17 |
| Medulloblastoma | 10 |
| Neuroblastoma | 8 |
| Sarcoma | 8 |
| Neoplasms | 7 |
| Oligodendroglioma | 7 |
| Glioma | 6 |
| Rhabdoid Tumor | 6 |
Trials
Showing 26 to 46 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.